Aplastic Anemia
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
We report false HLA genotyping results due to LOH and a coinciding steep rise in neutrophils following filgrastim stimulation in a patient with very severe aplastic anaemia.
|
28254831 |
2017 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
CTD_human |
Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.
|
16553037 |
2006 |
Aplastic Anemia
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.
|
16553037 |
2006 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
CTD_human |
[Efficacy of anti-thymocyte globulin and cyclosporin A combined therapy in aplastic anemia complicated with limited cutaneous systemic sclerosis].
|
15863969 |
2005 |
Aplastic Anemia
|
0.370 |
Therapeutic
|
disease |
CTD_human |
[Efficacy of anti-thymocyte globulin and cyclosporin A combined therapy in aplastic anemia complicated with limited cutaneous systemic sclerosis].
|
15863969 |
2005 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
BEFREE |
However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.
|
14607763 |
2003 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
BEFREE |
We report a case of AA progressing to overt MDS/AML following 11 years of treatment that included immunosuppressive therapy and G-CSF.
|
12393278 |
2002 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
CTD_human |
Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review.
|
10629575 |
2000 |
Aplastic Anemia
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review.
|
10629575 |
2000 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
BEFREE |
Absence of mutations in the granulocyte colony-stimulating factor (G-CSF) receptor gene in patients with myelodysplastic syndrome/acute myeloblastic leukaemia occurring after treatment of aplastic anaemia with G-CSF.
|
11122117 |
2000 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
CTD_human |
[Methimazole-induced aplastic anemia].
|
10544668 |
1999 |
Aplastic Anemia
|
0.370 |
Therapeutic
|
disease |
CTD_human |
[Methimazole-induced aplastic anemia].
|
10544668 |
1999 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
CTD_human |
Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.
|
9777751 |
1998 |
Aplastic Anemia
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.
|
9777751 |
1998 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
BEFREE |
The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction.
|
9236159 |
1997 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
BEFREE |
We suggest that it is important to pay close attention to the appearance of clonal hematopoiesis during the administration of G-CSF to patients with idiopathic severe bone marrow aplasia.
|
7524889 |
1994 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
BEFREE |
We studied mRNA expression of the cytokine granulocyte-colony stimulating factor (G-CSF), interleukin-1 beta (IL-1 beta), IL-6, IL-8 and stem cell factor of stromal cells derived from bone marrows of nine normal volunteers, eight patients with aplastic anaemia (AA) and seven patients with myelodysplastic syndrome (MDS).
|
7522519 |
1993 |
Aplastic Anemia
|
0.370 |
Biomarker
|
disease |
CTD_human |
Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids.
|
1642096 |
1992 |
Aplastic Anemia
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids.
|
1642096 |
1992 |